P3 Health Partners Inc Reports Q2 2025 EPS of -$6.23, Missing Estimates; Revenue at $355.8 Million, Slightly Below Expectations

P3 Health Partners reported Q2 EPS of $6.23, beating last year's $7.37. Revenue was $355.788M, below consensus of $359.43M. CEO Aric Coffman stated that the company's core business is strengthening and expects to achieve sustained profitability in 2026 due to its $130M EBITDA improvement plan and identified opportunities.

P3 Health Partners Inc. (PIII) reported its second-quarter (Q2) earnings, revealing an adjusted earnings per share (EPS) of -$6.23, which missed the Zacks Consensus Estimate of -$3.29 [3]. This compares to a loss of -$7.50 per share a year ago. The company's revenue for the quarter ended June 2025 was $355.79 million, falling short of the Zacks Consensus Estimate of $359.43 million [3].

The company's CEO, Aric Coffman, noted that while the results were disappointing, the core business is showing signs of improvement. He highlighted the company's $130 million EBITDA improvement plan and identified opportunities for further enhancements, expressing confidence in achieving sustained profitability by 2026 [2].

P3 Health Partners also reported a decline in membership, with a 9% year-over-year decrease, and a 6% year-over-year decrease in capitated revenue [2]. The company's adjusted EBITDA loss for the quarter was $17 million, or $50 per member per month (PMPM), improving to a loss of $8 million or $25 PMPM when adjusted for prior year items [2].

The company's liquidity position at the end of the quarter was $39 million, and its full-year 2025 adjusted EBITDA guidance was revised to a loss range of $39 million to $69 million [2]. CEO Coffman stated that the company is working closely with its plan partners to improve data exchange processes and has revamped its joint operating committee (JOC) processes to prevent future occurrences of similar issues [2].

P3 Health Partners shares have lost about 36.9% since the beginning of the year, compared to the S&P 500's gain of 10% [3]. The company's shares are currently expected to perform in line with the market in the near future, according to the Zacks Rank, which is #3 (Hold) [3].

References:
[1] https://seekingalpha.com/news/4485694-p3-health-partners-gaap-eps-of-6_23-misses-by-1_93-revenue-of-355_7m-misses-by-3_73m
[2] https://finance.yahoo.com/news/p3-health-partners-inc-piii-190448868.html
[3] https://www.nasdaq.com/articles/p3-health-partners-inc-piii-reports-q2-loss-lags-revenue-estimates